Antibody

ADT1056-Atidortoxumab Biosimilar-(alpha toxin)-Research Biosimilar Antibody

Alpha Lifetech offers flexible ordering options for biosimilar antibody products, providing both small and large quantities to suit different needs

COA datasheet MSDS

Products Categories

0102030405

recommended service

quick links

Product Background Product Specification FAQ

Product Background

Alpha Toxin is a 33 kDa pore-forming toxin that assembles into a heptameric β-barrel structure on host cell membranes.

Catalog Number	ADT1056
Product Name	ADT1056-Atidortoxumab Biosimilar-(alpha toxin)-Research Biosimilar Antibody
Alternate Names anti-alpha toxin antibody, anti alpha toxin antibody, recombinant alpha toxin, alpha toxin antibody, anti-alpha toxin monoclonal antibody, alpha toxin antibodies, alpha toxin recombinant antibody, alpha toxin blocking antibody
Alias	ASN-1, ASN-100 (combination of atidortoxumab and berlimatoxumab)
Clonity	Monoclonal
Host	CHO Cells
Species	Human
Target	alpha toxin
Isotype	IgG1 Kappa
Size	1mg, 5mg
Research Area	Immunology
CAS Number	1939108-95-8
Application	ELISA, WB
Purity	>95% as determined by SDS-PAGE
Concentration	batch dependent
Buffer	Supplied in PBS, PH7.5
Storage	Store at -20 °C for 12 months. Store at -80 °C for long term storage.
Shipping Condition	Shipped on ice packs.
Note	This product is for research use only.
Reference 1. Liu, S., et al. (2015). “The role of alpha-toxin in the pathogenesis of Staphylococcus aureus.” Frontiers in Microbiology, 6, 1-10. DOI: 10.3389/fmicb.2015.00100. 2. Bubeck Wardenburg, J., & Schneewind, O. (2008). “Vaccine protection against Staphylococcus aureus pneumonia.” The Journal of Experimental Medicine, 205(2), 287-294. DOI: 10.1084/jem.20071163. 3. Wang, Y., et al. (2014). “Alpha-toxin of Staphylococcus aureus induces apoptosis in human endothelial cells.” Microbial Pathogenesis, 77, 1-8. DOI: 10.1016/j.micpath.2014.09.001.